Ischemic heart disease: A patient-specific therapeutic approach with emphasis on quality of life considerations
- 29 July 1987
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 114 (1) , 251-257
- https://doi.org/10.1016/0002-8703(87)90974-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A multicenter trial of transdermal nitroglycerin in exercise-induced angina: Individual antianginal response after repeated administrationAmerican Heart Journal, 1986
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986
- In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty.Circulation, 1985
- Antianginöse Wirkung von transdermal appliziertem Nitroglycerin in Abhängigkeit von der PflastergrößeDeutsche Medizinische Wochenschrift (1946), 1985
- Failure of transdermal nitroglycerin to improve chronic stable angina: A randomized, placebo-controlled, double-blind, double crossover trialAmerican Heart Journal, 1984
- Trainsdermal nitroglycerin in angina pectorisThe American Journal of Cardiology, 1984
- Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups.Circulation, 1983
- Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.Circulation, 1983
- The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.Circulation, 1981
- Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries.Circulation, 1979